Polymyxin B, Colistin, and Sodium Colistimethate (Q40128513)

17 September 2017

1 reference

title

Polymyxin B, colistin, and sodium colistimethate (English)

1 reference

17 September 2017

Polymyxin B, Colistin, and Sodium Colistimethate (English)

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31447-X

14 September 2023

author name string

J. Horton

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6278236

14 September 2023

G. A. Pankey

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6278236

14 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6278236

14 September 2023

publication date

1 January 1982

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:S002571251631447X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31447-X

https://api.elsevier.com/content/article/PII:S002571251631447X?httpAccept=text/plain

14 September 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31447-X

Medical Clinics of North America

14 September 2023

published in

1 reference

17 September 2017

66

1 reference

17 September 2017

135-142

1 reference

17 September 2017

1

1 reference

‘Aerosporin’, an Antibiotic Produced by Bacillus aerosporus Greer

17 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Amikacin resistance developing in patients with Pseudomonas aeruginosa bronchopneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Inhibition of the Biologic Effects of Endotoxin on Neutrophils by Polymyxin B Sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Drug therapy in renal failure: dosing guidelines for adults. Part I: Antimicrobial agents, analgesics

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Diffuse Otitis Externa: Clinical and Microbiologic Findings in the Course of a Multicenter Study on a New Otic Solution

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

The Absorption of Antibiotics from the Bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Locus of divalent cation inhibition of the bactericidal action of polymyxin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Inactivation of endotoxin by polymyxin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Effect of Polymyxin B Sulfate on Endotoxin Activity in a Gram-Negative Septicemia Model

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Modification of human neutrophil response to endotoxin with polymyxin B sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Amikacin therapy of patients with multiply antibiotic-resistant Serratia marcescens infections: development of increasing resistance during therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Colistin sulphomethate sodium administration in the presence of severe renal failure and during haemodialysis and peritoneal dialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Antibiotics for Pseudomonas aeruginosa sepis: inadequate proof of efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Neuromuscular and cardiovascular depression produced by prolonged exposure to polymyxin b

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Respiratory Arrest in Myasthenia Gravis With Colistimethate Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Ventilatory effects of aerosolized kanamycin and polymyxin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Susceptibility of 1,500 isolates of Pseudomonas aeruginosa to gentamicin, carbenicillin, colistin, and polymyxin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Acute Renal Failure Associated With Sodium Colistimethate Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Polymyxin B-Induced Release of Low-Molecular-Weight, Heat-Labile Enterotoxin from Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Aerosol Polymyxin and Pneumonia in Seriously Ill Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Lethal Effect of Complement and Lysozyme on Polymyxin-Treated, Serum-Resistant Gram-Negative Bacilli

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Susceptibility of Beta-Hemolytic Streptococci to 65 Antibacterial Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Susceptibility of Pneumococci and Haemophilus influenzae to Antibacterial Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Serum and Urine Levels Following Parenteral Administration of Sodium Colistimethate to Normal Individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Prevention of wound infection after appendicectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

An unusual case of neuromuscular blockade seen with therapeutic blood levels of colistin methanesulfonate (Coly-Mycin)

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

The effects of renal impairment, peritoneal dialysis, and hemodialysis on serum sodium colistimethate levels

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Bronchial reactivity to inhaled polymyxin B in subjects with asthma and chronic obstructive bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Prevention of gram-negative bacillary pneumonia using aerosol polymyxin as prophylaxis. I. Effect on the colonization pattern of the upper respiratory tract of seriously ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Treatment of Pseudomonas keratitis in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Comparison of Antibiotic Therapy in Presumptive Bacterial Conjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Endotracheal antibiotics for the prevention of tracheobronchial infections in tracheotomized unconscious patients. A comparative study of gentamicin and aminosidin-polymyxin B combination

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Prevention of gram-negative bacillary pneumonia using polymyxin aerosol as prophylaxis. II. Effect on the incidence of pneumonia in seriously ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Binding of antibiotics to tissue homogenates.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Binding of polymyxin antibiotics to tissues: the major determinant of distribution and persistence in the body.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Polymyxin B reactions, IgE antibody, and T-cell deficiency. Immunochemical studies in a patient after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Letter: Endotoxaemia in liver cirrhosis: treatment with polymyxin B

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Reversible respiratory paralysis associated with polymyxin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Colistin Sulfate Ophthalmic in the Treatment of Ocular Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Infection control in intravenous therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Polymyxin inhalation therapeutic hazard.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Antibiotic susceptibility of gram-negative bacilli isolated from blood cultures. Results of tests with 35 agents and strains from 169 patients at Boston City Hospital during 1972.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

SERUM CONCENTRATIONS OF COLISTIN IN PATIENTS WITH NORMAL AND IMPAIRED RENAL FUNCTION

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Synergism of polymyxin and sulfonamides in L-forms of Staphylococcus aureus and Proteus mirabilis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Some aspects of neuromuscular blockade by polymyxin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

POLYMYXIN B AND COLISTIN. A CRITICAL COMPARISON

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Application of antibiotic ointment to the site of venous catheterization--a controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Analysis of Increasing Antibiotic Resistance of Klebsiella pneumoniae Relative to Changes in Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Polymyxin B and Rifampin: New Regimen for Multiresistant Serratia marcescens Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Interaction of complement and polymyxin with gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Treatment of gram-negative bacillary meningitis in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Endobronchial Polymyxin B: experimental observations in chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Combined activity of sulfamethoxazole, trimethoprim, and polymyxin B against gram-negative bacilli

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Colistimethate toxicity. Report of a fatal case in a previously healthy child

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Effect of polymyxin B on antibiotic-resistant Proteus mirabilis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Peritoneal dialysis in colistin intoxication: Report of a case

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Sulfamethoxazole-Trimethoprim-Polymyxin Therapy of Serious Multiply Drug-Resistant Serratia Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Myopathy caused by polymyxin E: functional disorder of the cell membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Identity of colistin and polymyxin E

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Neurotoxic and nephrotoxic effects of colistin in patients with renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Passage of chloramphenicol and sodium colistimethate into the cerebrospinal fluid. Studies of hydrocephalic children

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Endocarditis due to Pseudomonas aeruginosa in a heroin addict. Successful treatment with trimethoprim-Sulfamethoxazole mixture plus colistin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931447-X

7 January 2021

Polymyxin B sulfate modification of bacterial endotoxin: effects on the development of endotoxin shock in dogs

30

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31447-X

Chemical alterations in cell envelopes of polymyxin-resistant Pseudomonas aeruginosa isolates

14 September 2023

32

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31447-X

Effect of methylprednisolone and polymyxin B sulfate on endotoxin-induced inhibition of human neutrophil chemotaxis

14 September 2023

42

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31447-X

Extensive pseudomonal pneumonia ultimately responding to polymyxin therapy

14 September 2023

51

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31447-X

Emergence of resistance to amikacin during treatment of burn wounds: the role of antimicrobial susceptibility testing

14 September 2023

68

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31447-X

A clinical and experimental comparative study of sodium colistimethate and polymyxin B sulfate

14 September 2023

70

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31447-X

COLISTIN THERAPY IN INFANTS AND CHILDREN

14 September 2023

86

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31447-X

Topical antibiotic therapy of the contaminated myelomeningocele sac

14 September 2023

87

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31447-X

14 September 2023

Identifiers

0 references

1 reference